Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes (Q41081093)
Jump to navigation
Jump to search
scientific article published on October 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes |
scientific article published on October 1997 |
Statements
1 reference
Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes (English)
1 reference
C Denning
1 reference
J D Pitts
1 reference
1 October 1997
1 reference
1 reference
Identifiers
1 reference